GANNA BAETGE: Open Payments
NPI 1174883250 · LOS ALTOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,816 in 97 payments from 19 companies in 2025. Trend: 2023 $434 · 2024 $1,311 · 2025 $2,816
Food & beverage: $2,746Education: $70
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $633 |
| Novo Nordisk Inc | 17 | $464 |
| Lundbeck LLC | 7 | $285 |
| Axsome Therapeutics, Inc. | 2 | $193 |
| ViiV Healthcare Company | 4 | $165 |
| Lilly USA, LLC | 8 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $163 |
| ABBVIE INC. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Exact Sciences Corporation | 5 | $121 |
Products named: NURTEC ODT, Ozempic, REXULTI, VYEPTI, Symbravo, APRETUDE, XIFAXAN, ELIQUIS.
Industry payments across CA — which companies pay providers there.
